Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of TH104 for Moderate to Severe Pruritus in Primary Biliary Cholangitis: a Double-blind, Randomized, Placebo-controlled, Phase 2a Study

NCT06733519 is registered in ClinicalTrials.gov with Tharimmune Inc as lead sponsor.

NCT NCT06733519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06733519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of TH104 for Moderate to Severe Pruritus in Primary Biliary Cholangitis: a Double-blind, Randomized, Placebo-controlled, Phase 2a Study
Lead sponsor
Tharimmune Inc
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
June 1, 2027
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis, pruritus